Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection (Trivalent, Seasonal Influenza Vaccine, Active Ingredient Content: 6 μg HA/Strain/0.5 ml) for Children and Adolescents

NCT02387294 is registered in ClinicalTrials.gov with Fluart Innovative Vaccine Ltd, Hungary as lead sponsor.

NCT NCT02387294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02387294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection (Trivalent, Seasonal Influenza Vaccine, Active Ingredient Content: 6 μg HA/Strain/0.5 ml) for Children and Adolescents
Lead sponsor
Fluart Innovative Vaccine Ltd, Hungary
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2014
Completion date
December 31, 2014
Enrollment
120 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

human influenza